← All trials
NCT01912495
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 1, 2013
- Primary completion
- Aug 1, 2015
- Completion date
- Jan 1, 2016
- First posted
- —
- Last posted
- —
- Enrollment
- 65
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Erasmus University RotterdamLead sponsor
- Rijnstate HospitalCollaborator
- Utrecht UniversityCollaborator
- University of GroningenCollaborator
- Slotervaart HospitalCollaborator
- Radboud UniversityCollaborator
- Maastricht UniversityCollaborator
- Onze Lieve Vrouw HospitalCollaborator
- University of AmsterdamCollaborator
- Erasmus University RotterdamOverall official - principal investigator
- Erasmus University RotterdamReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.